Identity, environment and mental wellbeing in the veterinary profession

Mental health and career dissatisfaction are of increasing concern to the veterinary profession. The influence of identity on the psychological wellbeing of veterinarians has not been widely explored. Twelve recent veterinary graduates were enrolled in a private social media discussion group, and their identities investigated through narrative inquiry: a methodology which enables identity priorities to be extrapolated from stories of experience. Two distinct variants of the veterinary identity were identified: an academic, ‘diagnosis-focused’ identity, which prioritised definitive diagnosis and best-evidence treatment; and a broader ‘challenge-focused’ identity, where priorities additionally included engaging with the client, challenging environment or veterinary business. Contextual challenges (such as a client with limited finances or difficult interpersonal interactions) were seen as a source of frustration for those with a diagnosis-focused identity, as they obstructed the realisation of identity goals. Overcoming these challenges provided satisfaction to those with a challenge-focused identity. The employment environment of the graduates (general veterinary practice) provided more opportunities for those with a challenge-focused identity to realise identity goals, and more markers of emotional wellbeing were apparent in their stories. Markers of poor emotional health were evident in the stories of those with a diagnosis-focused identity

Magnetohydrodynamic simulations of black hole accretion

We discuss the results of three-dimensional magnetohydrodynamic simulations, using a pseudo-Newtonian potential, of thin disk (h/r ~ 0.1) accretion onto black holes. We find (i) that magnetic stresses persist within the marginally stable orbit, and (ii) that the importance of those stresses for the dynamics of the flow depends upon the strength of magnetic fields in the disk outside the last stable orbit. Strong disk magnetic fields (alpha > 0.1) lead to a gross violation of the zero-torque boundary condition at the last stable orbit, while weaker fields (alpha ~ 0.01) produce results more akin to traditional models for thin disk accretion onto black holes. Fluctuations in the magnetic field strength in the disk could lead to changes in the radiative efficiency of the flow on short timescales.Comment: 6 pages, to appear in proceedings, 20th Texas Symposium on Relativistic Astrophysics, eds J.C. Wheeler and H. Marte

Fragmentation of positronium in collision with He atoms

The absolute cross section for the fragmentation of positronium in collision with He atoms has been measured. The results are compared with available theories. The longitudinal energy distributions of positrons resulting from fragmentation have also been determined and are found to display a peak situated just below half the residual energy. This is suggestive of the occurrence of "electron loss to the continuum" in which the two residual charged particles lie in a low relative-velocity Coulomb-continuum state

Scattering and Pairing in Cuprate Superconductors

The origin of the exceptionally strong superconductivity of cuprates remains a subject of debate after more than two decades of investigation. Here we follow a new lead: The onset temperature for superconductivity scales with the strength of the anomalous normal-state scattering that makes the resistivity linear in temperature. The same correlation between linear resistivity and Tc is found in organic superconductors, for which pairing is known to come from fluctuations of a nearby antiferromagnetic phase, and in pnictide superconductors, for which an antiferromagnetic scenario is also likely. In the cuprates, the question is whether the pseudogap phase plays the corresponding role, with its fluctuations responsible for pairing and scattering. We review recent studies that shed light on this phase - its boundary, its quantum critical point, and its broken symmetries. The emerging picture is that of a phase with spin-density-wave order and fluctuations, in broad analogy with organic, pnictide, and heavy-fermion superconductors.Comment: To appear in Volume 1 of the Annual Review of Condensed Matter Physic

Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people

<i>Objectives</i>: To evaluate the cost effectiveness of 40 mg simvastatin daily continued for life in people of different ages with differing risks of vascular disease. Design A model developed from a randomised trial was used to estimate lifetime risks of vascular events and costs of treatment and hospital admissions in the United Kingdom. <i>Setting</i>: 69 hospitals in the UK. <i>Participants</i>: 20 536 men and women (aged 40-80) with coronary disease, other occlusive arterial disease, or diabetes. <i>Interventions</i>: 40 mg simvastatin daily versus placebo for an average of 5 years. <i>Main</i> <i>outcome</i> <i>measures</i>: Cost effectiveness of 40 mg simvastatin daily expressed as additional cost per life year gained. Major vascular event defined as non-fatal myocardial infarction or death from coronary disease, any stroke, or revascularisation procedure. Results were extrapolated to younger and older age groups at lower risk of vascular disease than were studied directly, as well as to lifetime treatment. <i>Results</i>: At the April 2005 UK price of £4.87 (€7; $9) per 28 day pack of generic 40 mg simvastatin, lifetime treatment was cost saving in most age groups and vascular disease risk groups studied directly. Gains in life expectancy and cost savings decreased with increasing age and with decreasing risk of vascular disease. People aged 40-49 with 5 year risks of major vascular events of 42% and 12% at start of treatment gained 2.49 and 1.67 life years, respectively. Treatment with statins remained cost saving or cost less than £2500 per life year gained in people as young as 35 years or as old as 85 with 5 year risks of a major vascular event as low as 5% at the start of treatment. <i>Conclusions</i>: Treatment with statins is cost effective in a wider population than is routinely treated at present